RankingsPricing
  1. US-listed companies
  2. CONMED Corp
  3. Financials
  4. Diluted EPS

CONMED CorpCNMD

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndDiluted EPS (USD)YoY (%)
Dec 31, 20244.3+108.33%
Dec 31, 20232-176.12%
Dec 31, 2022-2.7-238.14%
Dec 31, 20211.9+506.25%
Dec 31, 20200.3-67.01%
Dec 31, 20191-31.21%
Dec 31, 20181.4-28.43%
Dec 31, 20172+278.85%
Dec 31, 20160.5-52.29%
Dec 31, 20151.1-6.03%
Dec 31, 20141.2-9.38%
Dec 31, 20131.3-9.22%
Dec 31, 20121.4+4600.00%
Dec 31, 20110

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)